{
 "url": "https://etfiq.com/funds/pbph/holdings/",
 "section": "funds",
 "title": "PBPH Holdings: All 53 Positions (Jul 31, 2026) | ETFIQ",
 "description": "All 53 PBPH holdings with weights, as of Jul 31, 2026. The top 3 are LLY 15.20%, JNJ 9.66% and ABBV 6.94%. Download the full list as a CSV.",
 "as_of": "Jul 31, 2026",
 "ticker": "PBPH",
 "fund": "Portfolio Building Block World Pharma and Biotech Index ETF",
 "fund_page": "https://etfiq.com/funds/pbph",
 "positions": 53,
 "positions_listed_on_page": 53,
 "lead": "PBPH held 53 positions as of Jul 31, 2026. Eli Lilly & Co is the largest at 15.20%; the top 10 are 61.9% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/2043390/000200032426004430/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-07-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 15.197,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 2,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 9.658,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 3,
   "holding": "AbbVie Inc",
   "ticker": "ABBV",
   "weight_pct": 6.944,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 4,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 5.036,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 5,
   "holding": "Roche Holding AG",
   "ticker": "ROP",
   "weight_pct": 4.737,
   "page": "https://etfiq.com/holdings/rop-sw/"
  },
  {
   "rank": 6,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 4.635,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 7,
   "holding": "Novartis AG",
   "ticker": "NOVN",
   "weight_pct": 4.474,
   "page": "https://etfiq.com/holdings/novn/"
  },
  {
   "rank": 8,
   "holding": "Astrazeneca PLC",
   "ticker": "AZN",
   "weight_pct": 3.896,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 9,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 3.772,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 10,
   "holding": "Novo Nordisk A/S",
   "ticker": "NOVOB",
   "weight_pct": 3.51,
   "page": "https://etfiq.com/holdings/novob/"
  },
  {
   "rank": 11,
   "holding": "Pfizer Inc",
   "ticker": "PFE",
   "weight_pct": 3.326,
   "page": "https://etfiq.com/holdings/pfe/"
  },
  {
   "rank": 12,
   "holding": "Bristol-Myers Squibb Co",
   "ticker": "BMY",
   "weight_pct": 3.11,
   "page": "https://etfiq.com/holdings/bmy/"
  },
  {
   "rank": 13,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 2.818,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 14,
   "holding": "GSK PLC",
   "ticker": "GSK",
   "weight_pct": 2.259,
   "page": "https://etfiq.com/holdings/gsk-plc/"
  },
  {
   "rank": 15,
   "holding": "Sanofi SA",
   "ticker": "SAN",
   "weight_pct": 2.171,
   "page": "https://etfiq.com/holdings/san/"
  },
  {
   "rank": 16,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 1.786,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 17,
   "holding": "Bayer AG",
   "ticker": "BAYN",
   "weight_pct": 1.267,
   "page": "https://etfiq.com/holdings/bayn/"
  },
  {
   "rank": 18,
   "holding": "Takeda Pharmaceutical Company Ltd",
   "ticker": "4502",
   "weight_pct": 1.25,
   "page": "https://etfiq.com/holdings/tachem/"
  },
  {
   "rank": 19,
   "holding": "Argenx SE",
   "ticker": "ARGX",
   "weight_pct": 1.24,
   "page": "https://etfiq.com/holdings/argx/"
  },
  {
   "rank": 20,
   "holding": "CSL Ltd",
   "ticker": "CSL",
   "weight_pct": 1.111,
   "page": "https://etfiq.com/holdings/csl-ltd/"
  },
  {
   "rank": 21,
   "holding": "Teva Pharmaceutical Industries Ltd",
   "ticker": "TEVA",
   "weight_pct": 0.959,
   "page": "https://etfiq.com/holdings/teva/"
  },
  {
   "rank": 22,
   "holding": "Natera Inc",
   "ticker": "NTRA",
   "weight_pct": 0.846,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 23,
   "holding": "Sandoz Group AG",
   "ticker": "SDZ",
   "weight_pct": 0.775,
   "page": "https://etfiq.com/holdings/sdz/"
  },
  {
   "rank": 24,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 0.774,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 25,
   "holding": "Zoetis Inc",
   "ticker": "ZTS",
   "weight_pct": 0.757,
   "page": "https://etfiq.com/holdings/zts/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.55
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/pbph/holdings/pbph-holdings.csv",
 "json_book": "https://etfiq.com/data/books/pbph.json",
 "markdown": "https://etfiq.com/funds/pbph/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of PBPH, data as of Jul 31, 2026. https://etfiq.com/funds/pbph/holdings/"
}